Baxter International | BAX - Ebitda


Baxter International reported $309M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Dexcom USD 388.7M 24.2M Jun/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Fresenius EUR 988M 37M Jun/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Halozyme Therapeutics USD 328.81M 109.24M Jun/2026
ICU Medical USD 110.03M 11.35M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
J&J USD 8.99B 721M Jun/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Quest Diagnostics USD 627M 21M Sep/2026
Smith & Nephew USD 796M 139M Dec/2025
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 122.91M 47.28M Jun/2026
Terumo JPY 116.67B 58.79B Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026